This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that affects millions of people around the world. It is characterized by abdominal pain, bloating, and changes in bowel movements. Symptoms may be mild or severe and can be triggered by a variety of factors, including stress, diet, and certain medications. IBS is believed to be caused by a combination of physical and psychological factors. There is no single test that can diagnose IBS, so it is typically diagnosed through a combination of physical examination, medical history, and laboratory tests. The most common treatment for IBS is lifestyle changes, such as eating a balanced diet and avoiding foods that trigger symptoms. Stress management can also be beneficial. Medications, such as antispasmodics, antidepressants, and laxatives, may be prescribed to help relieve symptoms. Some people may benefit from therapies such as cognitive behavioral therapy (CBT) or hypnotherapy. IBS can be disruptive and can have a negative impact on quality of life, but there are ways to manage symptoms and improve overall health. Working with a healthcare provider to identify triggers, develop a plan to manage symptoms, and make lifestyle changes can be beneficial.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States